RN7SL577P

Across TCGA pan-cancer cohorts, RN7SL577P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL577P data layer.

The strongest signal is observed in adrenocortical carcinoma (ACC), where higher RN7SL577P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL577P expression acts as an unfavorable survival marker, although some lineages such as UCS and LUSC show a favorable association.

ACC, DLBC, and ESCA are the cancer types where RN7SL577P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ACC	OS	Tertile	All	0.310	0.651	.001	72	view →
DLBC	DFS	Tertile	II,III,IV	0.065	0.829	<.001	39	view →
ESCA	OS	Median	IV	0.222	0.698	.006	22	view →
GBM	OS	Tertile	All	0.254	0.453	.001	18	view →
UCS	DFS	Tertile	IV	0.996	0.570	.039	18	view →
LUAD	OS	Tertile	IV	0.174	0.597	.044	18	view →
LUSC	DFS	Tertile	II,III,IV	0.917	0.436	.012	15	view →
STAD	OS	Median	IV	0.593	0.147	.002	15	view →
READ	OS	Tertile	IV	0.557	0.883	.040	9	view →
PCPG	OS	Tertile	All	0.925	1.000	.017	9	view →
THCA	DFS	Quartile	II,III,IV	0.632	0.833	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL577P–ACC (OS)

Open the ACC breakdown →